Sign Up Today and Learn More About Adcentrx Therapeutics Stock
Invest in or calculate the value of your shares in Adcentrx Therapeutics or other pre-IPO companies through EquityZen's platform.
Adcentrx Therapeutics Stock (ADTH)
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
About Adcentrx Therapeutics Stock
Founded
2021
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Adcentrx Therapeutics Press Mentions
Stay in the know about the latest news on Adcentrx Therapeutics
Drug conjugates and methods of preparing and using the same
patents • Apr 02, 2025
Methods and compositions related to antibodies and antibody drug conjugates ( …
patents • Apr 02, 2025
Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025
biospace • Mar 26, 2025
Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025
morningstar • Mar 26, 2025
Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025
prnewswire • Mar 26, 2025
Adcentrx Therapeutics Management
Leadership team at Adcentrx Therapeutics
Founder, President and CEO
Hui Li
Join now and verify your accreditation status to gain access to:
- Adcentrx Therapeutics Current Valuation
- Adcentrx Therapeutics Stock Price
- Adcentrx Therapeutics Management
- Available deals in Adcentrx Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Adcentrx Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Adcentrx Therapeutics Revenue and Financials
- Adcentrx Therapeutics Highlights
- Adcentrx Therapeutics Business Model
- Adcentrx Therapeutics Risk Factors
- Adcentrx Therapeutics Research Report from SACRA Research
Trading Adcentrx Therapeutics Stock
How to invest in Adcentrx Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Adcentrx Therapeutics through EquityZen funds. These investments are made available by existing Adcentrx Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Adcentrx Therapeutics stock?
Shareholders can sell their Adcentrx Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
